MedTrace Logo

Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection

NCT04918212 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2021-11-08

No results posted yet for this study

Summary

A prospective, multi-center, objective performance criteria clinical trial to evaluate the safety and efficacy of Fabulous Stent Graft System manufactured by Hangzhou Endonom Medtech Co., Ltd. for Stanford B Aortic Dissection.

Conditions

  • Aortic Dissection Type B

Interventions

DEVICE

Fabulous Stent Graft System

All patients received endovascular surgery using fabulous stent graft system

Sponsors & Collaborators

  • Hangzhou Endonom Medtech Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-25
Primary Completion
2020-10-13
Completion
2020-10-13

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04918212 on ClinicalTrials.gov